淋巴结阳性子宫内膜癌中广泛淋巴播散与复发的预测因素
本研究回顾96例完全分期且至少1枚淋巴结阳性的子宫内膜癌患者的临床病理资料,复核转移淋巴结永久切片并按转移灶大小(≤2 mm与>2 mm)及囊内/囊外位置分类。盆腔宏转移合并子宫浆膜受累时多发盆腔淋巴结播散发生率为91.7%(两者均无时为7.7%);盆腔宏转移、淋巴血管间隙浸润(LVSI)与囊外侵犯并存时腹主动脉旁受累发生率为85.7%(三者均无时为11.1%);LVSI独立与非阴道复发相关(HR 2.62,95%CI 1.33-5.16)。
要点
- 盆腔宏转移合并子宫浆膜受累者多发盆腔淋巴结播散达91.7%,两者均无时仅7.7%。
- 盆腔宏转移、LVSI与囊外侵犯并存时腹主动脉旁受累达85.7%,三者均无时11.1%。
- LVSI独立与非阴道复发相关(HR 2.62,95%CI 1.33-5.16)。
核心结论
- 盆腔淋巴结高体积转移与多发盆腔阳性淋巴结及腹主动脉旁淋巴结受累相关。
- LVSI与腹主动脉旁淋巴结受累及非阴道复发均相关。
- 作者认为在前哨淋巴结标测时代,这些因素可能有助于预测子宫内膜癌的淋巴播散范围。
研究设计与样本
- 纳入96例完全分期且至少1枚淋巴结阳性的子宫内膜癌患者,收集临床病理资料。
- 复核转移淋巴结永久切片,按转移灶大小(≤2 mm与>2 mm)及囊内/囊外位置分类。
- 通过多因素分析识别的危险因素组合计算多发盆腔及腹主动脉旁淋巴结播散的发生风险。
主要发现
- 96例中85例盆腔淋巴结阳性,其中71例(83.5%)为高体积转移。
- 盆腔宏转移(OR 13.42,95%CI 2.44-73.83)合并最终病理子宫浆膜受累(OR 11.84,95%CI 1.22-115.11)时,多发盆腔淋巴结播散发生率为91.7%,两者均无时为7.7%。
- 盆腔宏转移、LVSI与囊外侵犯并存时腹主动脉旁受累发生率为85.7%,三者均无时为11.1%。
- LVSI独立与非阴道复发相关(HR 2.62,95%CI 1.33-5.16)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify predictors of extensive lymphatic dissemination and distant recurrences in node-positive endometrial cancer (EC). METHODS: Clinicopathologic data were collected of patients who had fully staged EC with at least 1 positive lymph node. Permanent sections of metastatic lymph nodes were reviewed; metastases were characterized according to size (≤2 mm and >2 mm) and location in the lymph node (intra- vs extracapsular). Risk of occurrence of multiple pelvic and para-aortic lymph node dissemination was calculated by combining risk factors identified at multivariate analysis. RESULTS: Of 96 patients, 85 had positive pelvic nodes, of whom 71 (83.5%) had high-volume metastases. In the presence of both macrometastasis in the pelvic basin (odds ratio [OR], 13.42; [95% CI, 2.44-73.83]) and uterine serosal involvement of the tumor at final pathologic evaluation (OR, 11.84 [95% CI, 1.22-115.11]), multiple pelvic node dissemination occurred in 91.7% of cases (vs 7.7% in the absence of both). Concomitant presence of pelvic macrometastasis, lymphovascular space invasion (LVSI), and extracapsular invasion led to 85.7% occurrence of para-aortic involvement (vs 11.1% if no factors present). LVSI was independently associated with nonvaginal recurrences (hazard ratio, 2.62 [95% CI, 1.33-5.16]). CONCLUSIONS: Presence of high-volume metastases in the pelvic lymph nodes is associated with concomitant presence of multiple positive pelvic nodes, as well as para-aortic node involvement. LVSI is associated with both para-aortic node involvement and occurrence of nonvaginal relapses. In this era of sentinel lymph node mapping, these factors may help predict the extent of lymphatic dissemination in EC.
引用
- Zanfagnin V, Huang Y, Mc Gree ME, et al. Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer. Gynecol Oncol. 2019. PMID: 31324453. doi:10.1016/j.ygyno.2019.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。